Immunisincis A Biotechnology Company Located In Irvinecaliforniafounded In 2020The Company Focuses On Developing Multi Active Biologics Aimed At Treating Age Related Diseases And Immune Dysfunctionit Specializes In Regenerative Medicineutilizing Advanced Stem Cell Technology To Create Innovative Therapeutic Products One Of Immuniskey Offerings Is Immune Secretome Productswhich Include Proteinslipidsgrowth Factorsand Other Molecules That Can Enhance Immune Cell Responsestheir Lead Productimm01 Stemhas Shown Promise In Improving Muscle Function And Metabolic Health In Elderly Individualsanother Productimmunais Being Investigated As A Non Invasive Treatment For Knee Osteoarthritispotentially Providing An Alternative To Surgery Immunis Has Completed A Phase 1 2A Clinical Trial For Imm01 Stemdemonstrating Safety And Efficacy In Improving Physical Function And Reducing Pain In Older Patientsthe Company Has Secured Funding For Further Clinical Trials To Evaluate The Product S Effectiveness In Addressing Muscle Loss And Metabolic Issues
